$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
索拉菲尼治疗肾癌效果如何?
2025-10-19 11:44:20
Check Details
卡博替尼治疗晚期RET重排肺癌2期研究
2025-10-19 11:44:20
Check Details
多吉美治疗肾癌效果看得见!
2025-10-19 11:44:20
Check Details
阿西替尼肾癌二线治疗用药
2025-10-19 11:44:20
Check Details
阿西替尼二线治疗转移性肾细胞癌患者的疗效
2025-10-19 11:44:20
Check Details
乐伐替尼肾细胞癌患者的二线治疗
2025-10-19 11:44:20
Check Details
卡博替尼在脑转移MET外显子14阳性肺癌中的颅内活性
2025-10-19 11:44:20
Check Details
舒尼替尼治疗晚期肾癌优于培唑帕尼
2025-10-19 11:44:20
Check Details
阿西替尼一线治疗晚期肾细胞癌的疗效
2025-10-19 11:44:20
Check Details
阿昔替尼二线治疗肾癌
2025-10-19 11:44:20
Check Details
卡博替尼3期转移性甲状腺髓样癌试验中RET和RAS突变相关性分析
2025-10-19 11:44:20
Check Details
肾癌患者服用多吉美用药指南
2025-10-19 11:44:20
Check Details
1
2
...
2106
2107
2108
2109
2110
2111
2112
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
2
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
3
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
4
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
5
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
6
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
7
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
8
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
9
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
10
Lapatinib: Proper Administration Guide and Key Precautions
11
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
12
Cemiplimab Storage and Handling Guide